- Home
- PBT vs AQST Comparison
PBT vs AQST Comparison
Compare PBT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBT | AQST |
|---|---|---|
| Founded | 1980 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 920.1M | 809.3M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | PBT | AQST |
|---|---|---|
| Price | $18.96 | $6.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 95.9K | ★ 2.7M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | $17,266,423.00 | ★ $43,397,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $52.69 |
| P/E Ratio | $56.92 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.01 | $2.12 |
| 52 Week High | $20.46 | $7.55 |
Technical Indicators
Market Signals| Indicator | PBT | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 51.37 | 60.24 |
| Support Level | $17.13 | $5.90 |
| Resistance Level | $19.37 | $6.55 |
| Average True Range (ATR) | 0.78 | 0.34 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 58.93 | 88.80 |
Price Performance
Historical ComparisonAbout PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.